• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用光动力疗法(PDT)治疗特发性黄斑旁毛细血管扩张症中的黄斑水肿消退情况。

Resolution of macular edema in idiopathic juxtafoveal telangiectasis using PDT.

作者信息

Kotoula Maria G, Chatzoulis Dimitrios Z, Karabatsas Constantinos H, Tsiloulis Aristoteles, Tsironi Evangelia E

机构信息

Department of Ophthalmology, University of Thessaly School of Medicine, Larissa, Greece.

出版信息

Ophthalmic Surg Lasers Imaging. 2009 Jan-Feb;40(1):65-7. doi: 10.3928/15428877-20090101-10.

DOI:10.3928/15428877-20090101-10
PMID:19205501
Abstract

A 57-year-old woman was treated by photodynamic therapy for macular edema due to idiopathic juxtafoveal telangiectasis (presumed type 1A) without subretinal neovascularization. Initial visual acuity of the treated eye was 20/200 and it improved to 20/40 by 3 months after the photodynamic therapy session. Visual acuity remained stable 32 months after the treatment. Color photographs and fundus fluorescein angiography before and after photodynamic therapy revealed regression of hemorrhages, exudates, and fluorescein leakage. Photodynamic therapy has long-term benefits for the patient with idiopathic juxtafoveal telangiectasis, presumed type 1A, because it can improve visual acuity and macular edema.

摘要

一名57岁女性因特发性黄斑旁毛细血管扩张症(推测为1A型)导致黄斑水肿且无视网膜下新生血管形成,接受了光动力疗法治疗。治疗眼的初始视力为20/200,在光动力治疗后3个月提高到了20/40。治疗后32个月视力保持稳定。光动力治疗前后的彩色照片和眼底荧光血管造影显示出血、渗出物和荧光素渗漏有所消退。光动力疗法对患有推测为1A型的特发性黄斑旁毛细血管扩张症的患者具有长期益处,因为它可以提高视力并减轻黄斑水肿。

相似文献

1
Resolution of macular edema in idiopathic juxtafoveal telangiectasis using PDT.使用光动力疗法(PDT)治疗特发性黄斑旁毛细血管扩张症中的黄斑水肿消退情况。
Ophthalmic Surg Lasers Imaging. 2009 Jan-Feb;40(1):65-7. doi: 10.3928/15428877-20090101-10.
2
Photodynamic therapy of a subretinal neovascular membrane in type 2A idiopathic juxtafoveolar retinal telangiectasis.2A型特发性黄斑旁视网膜毛细血管扩张症视网膜下新生血管膜的光动力疗法
Am J Ophthalmol. 2002 Jan;133(1):149-51. doi: 10.1016/s0002-9394(01)01205-3.
3
Photodynamic therapy and intravitreal triamcinolone for a subretinal neovascularization in bilateral idiopathic juxtafoveal telangiectasis.光动力疗法联合玻璃体内注射曲安奈德治疗双侧特发性黄斑旁毛细血管扩张症的视网膜下新生血管
Am J Ophthalmol. 2004 Nov;138(5):884-5. doi: 10.1016/j.ajo.2004.05.073.
4
Lack of apparent short-term benefit of photodynamic therapy in bilateral, acquired, parafoveal telangiectasis without subretinal neovascularization.
Am J Ophthalmol. 2004 Nov;138(5):892-4. doi: 10.1016/j.ajo.2004.06.010.
5
Photodynamic therapy of subfoveal neovascular membrane in type 2A idiopathic juxtafoveolar retinal telangiectasis.2A型特发性黄斑旁视网膜毛细血管扩张症中心凹下新生血管膜的光动力疗法
Am J Ophthalmol. 2004 May;137(5):812-9. doi: 10.1016/j.ajo.2003.11.076.
6
Photodynamic therapy with verteporfin for subretinal neovascularization secondary to bilateral idiopathic acquired juxtafoveolar telangiectasis.
Ophthalmic Surg Lasers Imaging. 2003 Jul-Aug;34(4):318-20.
7
Idiopathic juxtafoveal retinal telangiectasia.特发性黄斑旁视网膜毛细血管扩张症
Optometry. 2008 Nov;79(11):653-62. doi: 10.1016/j.optm.2008.04.099.
8
Macular edema associated with latanoprost use in a patient with idiopathic juxtafoveal retinal telangiectasis.
Jpn J Ophthalmol. 2008 Jan-Feb;52(1):68-70. doi: 10.1007/s10384-007-0495-5. Epub 2008 Mar 28.
9
Combined photodynamic therapy and intravitreal ranibizumab as primary treatment for subretinal neovascular membrane (SRNVM) associated with type 2 idiopathic macular telangiectasia.联合光动力疗法与玻璃体内注射雷珠单抗作为2型特发性黄斑毛细血管扩张症相关的视网膜下新生血管膜(SRNVM)的主要治疗方法。
Graefes Arch Clin Exp Ophthalmol. 2008 Apr;246(4):619-21. doi: 10.1007/s00417-007-0732-0. Epub 2008 Jan 12.
10
Intravitreal triamcinolone for the treatment of idiopathic juxtafoveal telangiectasis.玻璃体内注射曲安奈德治疗特发性黄斑旁毛细血管扩张症。
Retina. 2003 Feb;23(1):113-6. doi: 10.1097/00006982-200302000-00022.

引用本文的文献

1
Macular oedema in idiopathic macular telangiectasia type 1 responsive to aflibercept but not bevacizumab.1型特发性黄斑毛细血管扩张症中的黄斑水肿对阿柏西普有反应,但对贝伐单抗无反应。
Case Rep Ophthalmol Med. 2014;2014:219792. doi: 10.1155/2014/219792. Epub 2014 Oct 1.
2
Use of intravitreal bevacizumab injections to treat type 1 idiopathic macular telangiectasia.玻璃体内注射贝伐单抗治疗1型特发性黄斑毛细血管扩张症。
Graefes Arch Clin Exp Ophthalmol. 2012 Nov;250(11):1697-9. doi: 10.1007/s00417-011-1798-2. Epub 2011 Aug 24.
3
Clinical features of idiopathic juxtafoveal telangiectasis in Koreans.
韩国人特发性黄斑旁毛细血管扩张症的临床特征。
Korean J Ophthalmol. 2011 Aug;25(4):225-30. doi: 10.3341/kjo.2011.25.4.225. Epub 2011 Jul 22.
4
Intravitreal triamcinolone for management of idiopathic juxtafoveolar telangiectasis.玻璃体内注射曲安奈德治疗特发性黄斑旁毛细血管扩张症
Oman J Ophthalmol. 2010 Jan;3(1):38-40. doi: 10.4103/0974-620X.60023.